11 Oct 21. Edinburgh Imaging Radiochemistry - GP1
As the Edinburgh Imaging Radiochemistry facility temporarily closes for refurbishment, we look back at the facility's success with 18F-glycoprotein 1 (GP1) radiotracers.

The Edinburgh Imaging Radiochemistry facility was opened in 2010 & currently houses a cyclotron with supporting radiochemistry suites to create both GMP & research PET radiotracers.
The EI Radiochemistry facility has now temporarily closed for refurbishment.
18F-GP1 is a derivative of elarofiban with a high affinity for activated platelet glycoprotein IIb & IIIa. It has promising in vivo characteristics for thrombus (clot) imaging.
Edinburgh Imaging has carried out the first cardiac & neurological applications of this imaging tracer.
The Edinburgh Imaging facilities & radiochemistry team are integral to 18F-GP1 studies, both for production of the imaging tracer in our radiochemistry as well as the groundbreaking imaging using PET-CT & PET-MR in our Edinburgh Imaging QMRI facility.
We are currently involved with three 18F-GP1 studies:
- Biothrombus
- iThrombus &
- Myothrombus
Relevant links
Social media tags & titles
As the Edinburgh Imaging Radiochemistry facility temporarily closes for refurbishment, we look back at the facility's success with 18F-glycoprotein 1 (GP1) radiotracers.
@EdinUniMedicine @EdinburghBQ